Quantum biopharma (nasdaq: qntm) files a us federal lawsuit against cibc world markets, rbc dominion securities and others, seeking damages in excess of $700,000,000 usd, for possible stock price manipulation/spoofing

Christian attar law firm and freedman normand friedland llp, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused substantial damages to the company and its shareholders toronto, on / accesswire / october 21, 2024 / quantum biopharma ltd. (nasdaq:qntm)(cse:qntm)(fra:0k91) ("quantum biopharma" or the "company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces the company, on 20th october 2024, has filed a complaint in the united states district court for the southern district of new york alleging that cibc world markets (cibc), rbc dominion securities (rbc), and others (the "defendants") engaged in market manipulation schemes that violated section 10(b) and rule 10b-5(a) and (c) and section 9(a) of the securities exchange act of 1934.
QNTM Ratings Summary
QNTM Quant Ranking